TAYSHA GENE THERAPIES INC (TSHA) Institutional Ownership and Insiders Activity
TAYSHA GENE THERAPIES INC (TSHA) is widely held by institutional investors, with 198 firms reporting positions valued at approximately $1.51B based on SEC Form 13F filings for the quarter ended September 30, 2026.
Ra Capital Management, L.P. is the largest disclosed holder, reporting approximately $148.22M in TSHA holdings in its latest filing.
Institutional Holders
198
Total Reported Value
$1.51B
Largest Holder
Ra Capital Management, L.P.
Largest Position
$148.22M
Insider Transactions (90d)
0
Latest Filing Quarter
Q3 2026
New Institutional Positions
42
Funds Exiting Positions
28
Top Institutional Owners
View allInvestorReported Balance
- Ra Capital Management, L.P.$148.22M
- Goldman Sachs Group Inc$122.31M
- Avoro Capital Advisors Llc$116.34M
- Blackrock, Inc.$110.32M
- Vestal Point Capital, Lp$87.88M
TSHA News
All news- Heights Capital Management Inc Q2 2026 Portfolio Activity Analysis
Aug 18, 2026 · valut.ai
Related TSHA Institutional Insights:
- TSHA 13F Institutional Holders
- TSHA Superinvestors
- TSHA Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TSHA Insider Trading & SEC Form 4 Activity
- TSHA Articles
- Top Institutional Investor Stock Rankings